# Sacroiliac (SI) Joint Transfixing and Fusion: Meaningful Long Term Outcomes With Nevro1

> **NCT06909292** · — · RECRUITING · sponsor: **Nevro Corp** · enrollment: 180 (estimated)

## Conditions studied

- Sacroiliac Joint Dysfunction

## Interventions

- **DEVICE:** Sacroiliac Joint transfixing and fusion system (Nevro1)

## Key facts

- **NCT ID:** NCT06909292
- **Lead sponsor:** Nevro Corp
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-03
- **Primary completion:** 2027-03
- **Final completion:** 2027-06
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06909292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06909292, "Sacroiliac (SI) Joint Transfixing and Fusion: Meaningful Long Term Outcomes With Nevro1". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06909292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*